ICARDIAC
Dead / Cancelled — Cancelled — Section 8 (as of 05 Oct 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77225397
- Registration number
- 3391604
- Mark type
- Stylized text
- Filed
- 10 Jul 2007
- Published for opposition
- 18 Dec 2007
- Registered
- 04 Mar 2008
- Attorney of record
- Olli S. Baker
Goods and services
- Class 042 — Scientific and technological services: Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research on the subject of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff
Owner
- iCardiac Technologies, Rochester, NY, US
- iCardiac Technologies, Rochester, NY, US
- iCardiac Technologies, Rochester, NY, US
Prosecution history
- 19 Feb 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 05 Oct 2018 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 27 Dec 2017 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Mar 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 27 Mar 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 27 Mar 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 03 Mar 2014 — REGISTERED - SEC. 8 (6-YR) FILED
- 21 Mar 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Mar 2014 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Mar 2014 — TEAS SECTION 8 RECEIVED
- 12 May 2008 — UNDELIVERABLE MAIL - COURTESY COPY MAILED
- 04 Mar 2008 — REGISTERED-PRINCIPAL REGISTER
- 18 Dec 2007 — PUBLISHED FOR OPPOSITION
- 28 Nov 2007 — NOTICE OF PUBLICATION
- 15 Nov 2007 — LAW OFFICE PUBLICATION REVIEW COMPLETED